MCK · News · 20260806N
Acquisition / Partnership / Divestiture
MCKESSON CORP · 2026-08-06 · Importance 58 · Surprise 68 · In source text
McKesson is separating its Medical-Surgical Solutions business, which will be rebranded Wellverse in January 2027. Wellverse is expected to become an independent, publicly traded company through a potential IPO in the second half of 2027, subject to market conditions and regulatory approvals. The separation is supported by a $2.25 billion Term Loan B facility and McKesson’s prior $1.25 billion minority-interest sale to Apollo Global Management; the business was reportedly valued at approximately $13 billion and serves more than 336,000 customers.
Key facts
- A minority stake sale to Apollo Global Management recently valued McKesson Medical-Surgical at $13 billion, per Virginia Business. source
- McKesson established a $2.25 billion Term Loan B facility to support the Wellverse separation. source
- McKesson previously sold a $1.25 billion minority interest in MMS to Apollo Funds. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| assets | positive | contingent | — | A minority stake sale to Apollo Global Management recently valued McKesson Medical-Surgical at $13 billion, per Virginia Business. |
| liability | negative | committed | — | McKesson established a $2.25 billion Term Loan B facility to support the Wellverse separation. |